GlassScriptPhysician profile
Letitia A Carter
NPI 1093800179
$527.10
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $396 · 2022: $105 · 2024: $26.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $125.00 | 2021 | |
| Esperion Therapeutics, INC. | $78.29 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $59.63 | 2022 | |
| Lilly USA, LLC | $35.80 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.64 | 2022 | |
| Corium, LLC | $27.54 | 2021 | |
| Abbvie INC. | $26.30 | 2021 | |
| Sk Life Science, INC. | $26.15 | 2024 | |
| Novo Nordisk INC | $24.88 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $22.92 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.57 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.34 | 2021 | |
| Merck Sharp & Dohme LLC | $11.96 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.61 | 2021 | |
| Phadia US INC. | $11.47 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Letitia Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.